Plasma gelsolin levels in the diagnosis, prognosis, and treatment of lung complications of prematurity

Am J Respir Crit Care Med. 2012 Dec 1;186(11):1195-6. doi: 10.1164/ajrccm.186.11.1195.
No abstract available

Publication types

  • Comparative Study
  • Letter
  • Randomized Controlled Trial

MeSH terms

  • Biomarkers / blood
  • Bronchopulmonary Dysplasia / blood*
  • Bronchopulmonary Dysplasia / diagnosis
  • Bronchopulmonary Dysplasia / mortality
  • Bronchopulmonary Dysplasia / therapy*
  • Female
  • Gelsolin / blood*
  • Gestational Age
  • Humans
  • Infant, Newborn
  • Infant, Premature*
  • Infant, Very Low Birth Weight
  • Male
  • Nitric Oxide / metabolism
  • Pilot Projects
  • Prognosis
  • Respiration, Artificial / methods
  • Respiratory Distress Syndrome, Newborn / blood*
  • Respiratory Distress Syndrome, Newborn / diagnosis
  • Respiratory Distress Syndrome, Newborn / mortality
  • Respiratory Distress Syndrome, Newborn / therapy
  • Risk Assessment
  • Sensitivity and Specificity
  • Severity of Illness Index
  • Survival Rate
  • Treatment Outcome

Substances

  • Biomarkers
  • Gelsolin
  • Nitric Oxide